Symbols / OPCH Stock $19.52 -2.16% Option Care Health, Inc.

Healthcare • Medical Care Facilities • United States • NMS
OPCH (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Care Facilities
CEO Mr. John Charles Rademacher
Exch · Country NMS · United States
Market Cap 3.07B
Enterprise Value 4.15B
Income 206.19M
Sales 5.67B
FCF (ttm) 168.69M
Book/sh 8.61
Cash/sh 1.16
Employees 6,528
Insider 10d —
IPO Aug 15, 1996
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 15.25
Forward P/E 9.51
PEG 1.12
P/S 0.54
P/B 2.27
P/C —
EV/EBITDA 10.35
EV/Sales 0.73
Quick Ratio 1.01
Current Ratio 1.64
Debt/Eq 94.01
LT Debt/Eq —
EPS (ttm) 1.28
EPS next Y 2.05
EPS Growth 3.40%
Revenue Growth 1.30%
EPS Gr Q/Q -3.00%
Rev Gr Q/Q —
Earnings (next) 2026-07-29
Earnings (prior) 2026-04-30
ROA 6.19%
ROE 15.26%
ROIC —
Gross Margin 19.18%
Oper. Margin 5.37%
Profit Margin 3.64%
Shs Outstand 157.03M
Shs Float 146.88M
Insider Own 1.14%
Instit Own 109.71%
Short Float 9.54%
Short Ratio 4.49
Short Interest 10.94M
52W High 36.80
vs 52W High -46.96%
52W Low 18.01
vs 52W Low 8.38%
Beta 0.68
Impl. Vol. 38.72%
Rel Volume 1.15
Avg Volume 2.73M
Volume 3.14M
Target (mean) $29.18
Tgt Median $30.00
Tgt Low $22.00
Tgt High $39.00
# Analysts 11
Recom Buy
Prev Close $19.95
Price $19.52
Change -2.16%
About

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$29.18
Mean price target
2. Current target
$19.52
Latest analyst target
3. DCF / Fair value
$19.34
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$19.52
Low
$22.00
High
$39.00
Mean
$29.18

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-06 main Morgan Stanley Overweight → Overweight $485
2026-05-04 main JP Morgan Overweight → Overweight $33
2026-05-01 main Barrington Research Outperform → Outperform $32
2026-05-01 main UBS Buy → Buy $39
2026-05-01 main TD Cowen Hold → Hold $23
2026-01-16 main Barrington Research Outperform → Outperform $42
2026-01-13 main Morgan Stanley Overweight → Overweight $38
2026-01-13 reit Citizens Market Outperform → Market Outperform $38
2025-12-11 init Stephens & Co. — → Overweight $40
2025-12-09 main B of A Securities Buy → Buy $35
2025-12-09 main Deutsche Bank Buy → Buy $36
2025-11-03 main TD Cowen Hold → Hold $27
2025-10-31 main Citizens Market Outperform → Market Outperform $36
2025-10-31 main Barrington Research Outperform → Outperform $38
2025-10-17 init Morgan Stanley — → Overweight $35
2025-10-02 init TD Cowen — → Hold $30
2025-09-23 main Barrington Research Outperform → Outperform $38
2025-07-31 main JMP Securities Market Outperform → Market Outperform $38
2025-07-10 main Barrington Research Outperform → Outperform $38
2025-06-18 reit JMP Securities Market Outperform → Market Outperform $36
News
RSS: Latest OPCH news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-07 SULLIVAN TIMOTHY P Director — 24,154 $20.69 $499,671
2026-05-04 KRAEMER HARRY M. JANSEN JR. Director — 36,610 $21.41 $783,773
2026-05-04 SETHNA MEENAL Chief Financial Officer — 16,225 $20.16 $327,075
2026-05-04 RADEMACHER JOHN CHARLES Chief Executive Officer — 12,500 $21.18 $264,706
2026-02-27 BAVARO MICHAEL Officer — 6,000 $33.00 $198,000
2026-02-27 PATE R CARTER Director — 30,287 $32.05 $970,620
2026-02-20 RADEMACHER JOHN CHARLES Chief Executive Officer — 11,087 — —
2026-02-18 SMYSER COLLIN General Counsel — 15,213 $0.00 $0
2026-02-18 WHITWORTH LUKE Chief Operating Officer — 30,423 $0.00 $0
2026-02-18 BAVARO MICHAEL Officer — 9,579 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
5,649.52
+13.03%
4,998.20
+16.17%
4,302.32
+9.06%
3,944.74
Operating Revenue
5,649.52
+13.03%
4,998.20
+16.17%
4,302.32
+9.06%
3,944.74
Cost Of Revenue
4,561.62
+14.46%
3,985.21
+20.00%
3,321.10
+7.90%
3,077.82
Reconciled Cost Of Revenue
4,558.47
+14.46%
3,982.62
+20.03%
3,318.10
+7.98%
3,072.95
Gross Profit
1,087.89
+7.39%
1,012.99
+3.24%
981.22
+13.19%
866.92
Operating Expense
749.99
+8.51%
691.16
+3.68%
666.63
+6.37%
626.69
Selling General And Administration
682.45
+8.28%
630.25
+3.76%
607.43
+7.30%
566.12
Total Expenses
5,311.61
+13.58%
4,676.37
+17.27%
3,987.73
+7.65%
3,704.50
Operating Income
337.91
+4.99%
321.83
+2.30%
314.60
+30.96%
240.23
Total Operating Income As Reported
337.91
+4.99%
321.83
+2.30%
314.60
+30.96%
240.23
EBITDA
408.15
+3.03%
396.13
-16.11%
472.19
+45.29%
325.01
Normalized EBITDA
408.15
+3.03%
396.13
-16.11%
472.19
+45.29%
325.01
Reconciled Depreciation
70.69
+11.33%
63.50
+2.09%
62.20
-4.94%
65.43
EBIT
337.46
+1.45%
332.63
-18.87%
409.99
+57.95%
259.57
Net Income
207.59
-2.00%
211.82
-20.69%
267.09
+77.40%
150.56
Pretax Income
282.90
-0.25%
283.60
-20.95%
358.74
+74.34%
205.77
Net Non Operating Interest Income Expense
-54.56
-11.28%
-49.03
+4.33%
-51.25
+4.75%
-53.81
Interest Expense Non Operating
54.56
+11.28%
49.03
-4.33%
51.25
-4.75%
53.81
Net Interest Income
-54.56
-11.28%
-49.03
+4.33%
-51.25
+4.75%
-53.81
Interest Expense
54.56
+11.28%
49.03
-4.33%
51.25
-4.75%
53.81
Other Income Expense
-0.45
-104.15%
10.79
-88.68%
95.39
+393.18%
19.34
Other Non Operating Income Expenses
-7.86
-262.64%
4.83
-94.62%
89.86
+532.05%
14.22
Tax Provision
75.31
+4.93%
71.78
-21.69%
91.65
+66.00%
55.21
Tax Rate For Calcs
0.00
+5.10%
0.00
-0.94%
0.00
-4.67%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
207.59
-2.00%
211.82
-20.69%
267.09
+77.40%
150.56
Net Income From Continuing Operation Net Minority Interest
207.59
-2.00%
211.82
-20.69%
267.09
+77.40%
150.56
Net Income From Continuing And Discontinued Operation
207.59
-2.00%
211.82
-20.69%
267.09
+77.40%
150.56
Net Income Continuous Operations
207.59
-2.00%
211.82
-20.69%
267.09
+77.40%
150.56
Normalized Income
207.59
-2.00%
211.82
-20.69%
267.09
+77.40%
150.56
Net Income Common Stockholders
207.59
-2.00%
211.82
-20.69%
267.09
+77.40%
150.56
Diluted EPS
1.27
+3.25%
1.23
-16.89%
1.48
+78.31%
0.83
Basic EPS
1.28
+4.07%
1.23
-17.45%
1.49
+79.52%
0.83
Basic Average Shares
162.10
-5.52%
171.57
-4.14%
178.97
-1.18%
181.10
Diluted Average Shares
163.37
-5.48%
172.84
-4.17%
180.38
-0.93%
182.07
Diluted NI Availto Com Stockholders
207.59
-2.00%
211.82
-20.69%
267.09
+77.40%
150.56
Depreciation Amortization Depletion Income Statement
67.54
+10.88%
60.91
+2.89%
59.20
-2.25%
60.56
Depreciation And Amortization In Income Statement
67.54
+10.88%
60.91
+2.89%
59.20
-2.25%
60.56
Earnings From Equity Interest
7.41
+24.23%
5.96
+7.85%
5.53
+7.90%
5.12
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
3,455.77
+0.99%
3,421.74
+6.36%
3,217.03
+3.34%
3,112.94
Current Assets
1,264.97
-4.36%
1,322.63
+20.87%
1,094.26
+10.05%
994.34
Cash Cash Equivalents And Short Term Investments
232.62
-43.62%
412.56
+19.98%
343.85
+16.88%
294.19
Cash And Cash Equivalents
232.62
-43.62%
412.56
+19.98%
343.85
+16.88%
294.19
Receivables
473.57
+15.58%
409.73
+8.49%
377.66
+0.03%
377.54
Accounts Receivable
473.57
+15.58%
409.73
+8.49%
377.66
+0.03%
377.54
Inventory
471.15
+21.39%
388.13
+41.65%
274.00
+22.17%
224.28
Prepaid Assets
—
—
—
—
Other Current Assets
87.63
-21.90%
112.20
+13.63%
98.74
+0.42%
98.33
Total Non Current Assets
2,190.80
+4.37%
2,099.12
-1.11%
2,122.78
+0.20%
2,118.60
Net PPE
230.49
+7.76%
213.90
+4.45%
204.79
+13.30%
180.75
Gross PPE
360.30
+7.73%
334.44
+1.76%
328.66
+8.57%
302.71
Accumulated Depreciation
-129.81
-7.69%
-120.54
+2.69%
-123.87
-1.56%
-121.97
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
86.69
+22.82%
70.59
-4.82%
74.17
+10.94%
66.85
Construction In Progress
19.21
-16.45%
22.99
-31.72%
33.67
+14.47%
29.41
Other Properties
127.75
+2.87%
124.19
+2.55%
121.10
+12.79%
107.37
Leases
126.65
+8.55%
116.67
+17.00%
99.72
+0.65%
99.08
Goodwill And Other Intangible Assets
1,915.92
+4.06%
1,841.26
-1.83%
1,875.64
-1.15%
1,897.54
Goodwill
1,606.74
+4.32%
1,540.25
+0.00%
1,540.25
+0.44%
1,533.42
Other Intangible Assets
309.18
+2.71%
301.01
-10.25%
335.40
-7.89%
364.12
Non Current Deferred Assets
—
—
—
0.00
Non Current Deferred Taxes Assets
—
—
—
0.00
Other Non Current Assets
44.39
+0.98%
43.97
+3.82%
42.35
+5.05%
40.31
Total Liabilities Net Minority Interest
2,129.38
+5.55%
2,017.51
+12.37%
1,795.36
+3.97%
1,726.83
Current Liabilities
829.35
+6.31%
780.15
+26.17%
618.31
+9.37%
565.35
Payables And Accrued Expenses
728.16
+5.75%
688.56
+37.29%
501.52
+8.31%
463.06
Payables
639.83
+4.76%
610.78
+43.20%
426.51
+12.61%
378.76
Accounts Payable
639.83
+4.76%
610.78
+43.20%
426.51
+12.61%
378.76
Current Accrued Expenses
88.33
+13.56%
77.78
+3.70%
75.01
-11.02%
84.30
Pensionand Other Post Retirement Benefit Plans Current
70.41
+11.72%
63.03
-31.87%
92.51
+20.29%
76.91
Current Debt And Capital Lease Obligation
30.78
+7.77%
28.56
+17.62%
24.28
-4.34%
25.38
Current Debt
6.78
+4.12%
6.51
+8.53%
6.00
+0.00%
6.00
Other Current Borrowings
6.78
+4.12%
6.51
+8.53%
6.00
+0.00%
6.00
Current Capital Lease Obligation
24.00
+8.86%
22.04
+20.60%
18.28
-5.69%
19.38
Total Non Current Liabilities Net Minority Interest
1,300.03
+5.06%
1,237.36
+5.12%
1,177.05
+1.34%
1,161.48
Long Term Debt And Capital Lease Obligation
1,242.57
+4.47%
1,189.42
+4.14%
1,142.13
+1.11%
1,129.64
Long Term Debt
1,154.05
+4.47%
1,104.64
+4.54%
1,056.65
-0.15%
1,058.20
Long Term Capital Lease Obligation
88.52
+4.42%
84.78
-0.83%
85.48
+19.66%
71.44
Non Current Deferred Liabilities
56.02
+17.75%
47.58
+36.24%
34.92
+57.62%
22.15
Non Current Deferred Taxes Liabilities
56.02
+17.75%
47.58
+36.24%
34.92
+57.62%
22.15
Other Non Current Liabilities
1.44
+292.90%
0.37
—
9.68
Stockholders Equity
1,326.39
-5.54%
1,404.24
-1.23%
1,421.67
+2.57%
1,386.10
Common Stock Equity
1,326.39
-5.54%
1,404.24
-1.23%
1,421.67
+2.57%
1,386.10
Capital Stock
0.02
+0.00%
0.02
+0.00%
0.02
+0.00%
0.02
Common Stock
0.02
+0.00%
0.02
+0.00%
0.02
+0.00%
0.02
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
184.52
+0.37%
183.85
+0.51%
182.91
+0.31%
182.34
Ordinary Shares Number
156.86
-5.66%
166.26
-4.76%
174.58
-4.06%
181.96
Treasury Shares Number
27.66
+57.31%
17.59
+111.11%
8.33
+2070.85%
0.38
Additional Paid In Capital
1,263.55
+2.61%
1,231.43
+2.26%
1,204.27
+2.33%
1,176.91
Retained Earnings
876.92
+31.01%
669.34
+46.30%
457.51
+140.26%
190.42
Gains Losses Not Affecting Retained Earnings
4.11
-62.83%
11.05
-26.25%
14.98
-29.21%
21.16
Treasury Stock
818.20
+61.19%
507.60
+98.97%
255.11
+10516.19%
2.40
Other Equity Adjustments
4.11
-62.83%
11.05
-26.25%
14.98
-29.21%
21.16
Total Equity Gross Minority Interest
1,326.39
-5.54%
1,404.24
-1.23%
1,421.67
+2.57%
1,386.10
Total Capitalization
2,480.45
-1.13%
2,508.88
+1.23%
2,478.32
+1.39%
2,444.31
Working Capital
435.62
-19.70%
542.48
+13.98%
475.95
+10.95%
428.99
Invested Capital
2,487.22
-1.12%
2,515.39
+1.25%
2,484.32
+1.39%
2,450.31
Total Debt
1,273.35
+4.55%
1,217.97
+4.42%
1,166.41
+0.99%
1,155.03
Net Debt
928.21
+32.87%
698.59
-2.81%
718.80
-6.65%
770.02
Capital Lease Obligations
112.52
+5.33%
106.82
+2.95%
103.76
+14.25%
90.82
Net Tangible Assets
-589.53
-34.90%
-437.02
+3.73%
-453.97
+11.24%
-511.44
Tangible Book Value
-589.53
-34.90%
-437.02
+3.73%
-453.97
+11.24%
-511.44
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
258.45
-20.08%
323.39
-12.90%
371.30
+38.78%
267.55
Cash Flow From Continuing Operating Activities
258.45
-20.08%
323.39
-12.90%
371.30
+38.78%
267.55
Net Income From Continuing Operations
207.59
-2.00%
211.82
-20.69%
267.09
+77.40%
150.56
Depreciation Amortization Depletion
70.69
+11.33%
63.50
+2.09%
62.20
-4.94%
65.43
Depreciation And Amortization
70.69
+11.33%
63.50
+2.09%
62.20
-4.94%
65.43
Other Non Cash Items
30.19
+32.96%
22.70
+4.46%
21.73
-9.50%
24.02
Stock Based Compensation
39.96
+10.55%
36.14
+18.58%
30.48
+81.61%
16.78
Deferred Tax
8.44
-33.29%
12.66
-0.86%
12.77
-74.05%
49.19
Deferred Income Tax
8.44
-33.29%
12.66
-0.86%
12.77
-74.05%
49.19
Operating Gains Losses
-2.67
+52.30%
-5.59
-1.03%
-5.53
+61.94%
-14.53
Change In Working Capital
-99.75
-392.69%
-20.25
+5.59%
-21.45
+27.98%
-29.78
Change In Receivables
-54.59
-70.20%
-32.08
-14419.20%
0.22
+100.61%
-36.89
Changes In Account Receivables
-54.59
-70.20%
-32.08
-14419.20%
0.22
+100.61%
-36.89
Change In Inventory
-81.47
+28.62%
-114.13
-123.78%
-51.00
-24.36%
-41.01
Change In Prepaid Assets
17.76
+213.81%
-15.60
-148.03%
-6.29
+62.56%
-16.80
Change In Payables And Accrued Expense
35.71
-77.69%
160.05
+160.15%
61.52
-39.48%
101.65
Change In Accrued Expense
16.19
+169.33%
-23.35
-268.95%
13.82
+399.78%
2.77
Change In Payable
19.52
-89.35%
183.40
+284.45%
47.70
-51.76%
98.89
Change In Account Payable
19.52
-89.35%
183.40
+284.45%
47.70
-51.76%
98.89
Change In Other Working Capital
6.88
+101.20%
3.42
+140.85%
-8.37
+45.41%
-15.34
Change In Other Current Liabilities
-24.03
-9.69%
-21.91
-25.00%
-17.53
+18.07%
-21.39
Investing Cash Flow
-161.08
-341.69%
-36.47
+35.46%
-56.51
+47.70%
-108.05
Cash Flow From Continuing Investing Activities
-161.08
-341.69%
-36.47
+35.46%
-56.51
+47.70%
-108.05
Net PPE Purchase And Sale
-41.31
-16.01%
-35.61
+14.95%
-41.87
-18.41%
-35.36
Purchase Of PPE
-41.31
-16.01%
-35.61
+14.95%
-41.87
-18.41%
-35.36
Capital Expenditure
-41.31
-16.01%
-35.61
+14.95%
-41.87
-18.41%
-35.36
Net Business Purchase And Sale
-117.25
0.00
+100.00%
-12.49
+85.70%
-87.36
Purchase Of Business
-117.25
0.00
+100.00%
-12.49
+85.70%
-87.36
Net Other Investing Changes
-2.53
-192.71%
-0.86
+59.74%
-2.15
-114.63%
14.67
Financing Cash Flow
-277.31
-27.08%
-218.21
+17.70%
-265.13
-1836.48%
15.27
Cash Flow From Continuing Financing Activities
-277.31
-27.08%
-218.21
+17.70%
-265.13
-1836.48%
15.27
Net Issuance Payments Of Debt
44.28
+1.62%
43.58
+826.25%
-6.00
+0.00%
-6.00
Issuance Of Debt
229.47
+359.32%
49.96
0.00
0.00
Repayment Of Debt
-185.19
-2800.85%
-6.38
-6.40%
-6.00
+0.00%
-6.00
Long Term Debt Issuance
229.47
+359.32%
49.96
0.00
0.00
Long Term Debt Payments
-185.19
-2800.85%
-6.38
-6.40%
-6.00
+0.00%
-6.00
Net Long Term Debt Issuance
44.28
+1.62%
43.58
+826.25%
-6.00
+0.00%
-6.00
Net Common Stock Issuance
-309.95
-22.64%
-252.73
-0.98%
-250.26
0.00
Common Stock Payments
-309.95
-22.64%
-252.73
-0.98%
-250.26
0.00
Repurchase Of Capital Stock
-309.95
-22.64%
-252.73
-0.98%
-250.26
0.00
Proceeds From Stock Option Exercised
-10.60
+14.40%
-12.38
-297.50%
-3.12
-114.65%
21.27
Net Other Financing Charges
-1.04
-131.17%
3.33
+157.86%
-5.75
—
Changes In Cash
-179.94
-361.86%
68.72
+38.36%
49.66
-71.58%
174.76
Beginning Cash Position
412.56
+19.98%
343.85
+16.88%
294.19
+146.34%
119.42
End Cash Position
232.62
-43.62%
412.56
+19.98%
343.85
+16.88%
294.19
Free Cash Flow
217.14
-24.55%
287.79
-12.64%
329.43
+41.88%
232.19
Interest Paid Supplemental Data
64.66
-9.64%
71.55
+2.51%
69.80
+38.58%
50.37
Income Tax Paid Supplemental Data
67.29
+4.29%
64.52
-14.25%
75.24
+459.91%
13.44
Common Stock Issuance
—
—
—
0.00
Dividend Received CFO
4.00
+66.67%
2.40
-40.00%
4.00
-31.91%
5.88
Earnings Losses From Equity Investments
-7.41
-24.23%
-5.96
-7.85%
-5.53
-7.90%
-5.12
Issuance Of Capital Stock
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category